Anthony Villani1, Rebecca McClure2, Michelle Barrett2, David Scott3. 1. School of Health and Sport Sciences, University of the Sunshine Coast, Queensland, Australia. Electronic address: avillani@usc.edu.au. 2. School of Health and Sport Sciences, University of the Sunshine Coast, Queensland, Australia. 3. Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria 3168, Australia; Department of Medicine and Australian Institute of Musculoskeletal Science, Melbourne Medical School - Western Campus, The University of Melbourne, St Albans, Victoria, 3021, Australia.
Abstract
AIM: We aimed to compare diagnostic differences for identification of sarcopenia using the original operational definition developed by the European Working Group on Sarcopenia in Older People (EWGSOP1) and the most recently revised EWGSOP2 definition in community dwelling older adults with type 2 diabetes mellitus (T2DM). METHODS: Appendicular Lean Mass (ALM) corrected for height (ALM/m2) was assessed by dual energy X-ray absorptiometry. Muscle strength was assessed using hand-grip strength (HGS) or chair stands, and the Short Physical Performance Battery (SPPB) and gait speed were used to evaluate lower extremity physical function. Cohen's kappa (κ) statistic was applied to determine the degree of agreement between the two definitions. Chi-square analysis with Bonferroni post hoc corrections were applied to determine differences in the prevalence of sarcopenic case-findings. RESULTS: A total of n = 87 older adults (71.2 ± 8.2 years; 66.7% males; BMI: 29.5 ± 5.8 kg/m2) were included. Agreement between the two definitions was low and non-significant (κ value = 0.118; P = 0.144). Significantly more cases of sarcopenia were identified when applying the EWGSOP1 definition (EWGSOP1: n = 6 (7%); EWGSOP2: n = 2 (2%); P = 0.004). No sex specific differences were observed. Only 2 of the 6 (33.3%) cases of sarcopenia identified by EWGSOP1 were also identified as sarcopenic when applying the EWGSOP2 diagnostic criteria. CONCLUSIONS: We showed significant discordance and limited overlap in the number of sarcopenic case-findings when applying both EWGSOP definitions. It is unknown as to whether the new diagnostic criteria are better at identifying adverse clinical outcomes in patients with T2DM. Future investigation is therefore warranted.
AIM: We aimed to compare diagnostic differences for identification of sarcopenia using the original operational definition developed by the European Working Group on Sarcopenia in Older People (EWGSOP1) and the most recently revised EWGSOP2 definition in community dwelling older adults with type 2 diabetes mellitus (T2DM). METHODS: Appendicular Lean Mass (ALM) corrected for height (ALM/m2) was assessed by dual energy X-ray absorptiometry. Muscle strength was assessed using hand-grip strength (HGS) or chair stands, and the Short Physical Performance Battery (SPPB) and gait speed were used to evaluate lower extremity physical function. Cohen's kappa (κ) statistic was applied to determine the degree of agreement between the two definitions. Chi-square analysis with Bonferroni post hoc corrections were applied to determine differences in the prevalence of sarcopenic case-findings. RESULTS: A total of n = 87 older adults (71.2 ± 8.2 years; 66.7% males; BMI: 29.5 ± 5.8 kg/m2) were included. Agreement between the two definitions was low and non-significant (κ value = 0.118; P = 0.144). Significantly more cases of sarcopenia were identified when applying the EWGSOP1 definition (EWGSOP1: n = 6 (7%); EWGSOP2: n = 2 (2%); P = 0.004). No sex specific differences were observed. Only 2 of the 6 (33.3%) cases of sarcopenia identified by EWGSOP1 were also identified as sarcopenic when applying the EWGSOP2 diagnostic criteria. CONCLUSIONS: We showed significant discordance and limited overlap in the number of sarcopenic case-findings when applying both EWGSOP definitions. It is unknown as to whether the new diagnostic criteria are better at identifying adverse clinical outcomes in patients with T2DM. Future investigation is therefore warranted.
Authors: Ming Li Yee; Raphael Hau; Alison Taylor; Mark Guerra; Peter Guerra; Peteris Darzins; Christopher Gilfillan Journal: Osteoporos Sarcopenia Date: 2020-07-18
Authors: Francesc Formiga; Rafael Moreno-González; Andrea Corsonello; Axel Carlsson; Johan Ärnlöv; Francesco Mattace-Raso; Tomasz Kostka; Christian Weingart; Regina Roller-Wirnsberger; Lisanne Tap; Agnieszka Guligowska; Cornel Sieber; Gerhard Wirnsberger; Rada Artzi-Medvedik; Ilan Yehoshua; Cinzia Giuli; Fabrizia Lattanzio; Xavier Corbella Journal: BMC Geriatr Date: 2022-03-28 Impact factor: 3.921
Authors: Luisa Lampignano; Ilaria Bortone; Fabio Castellana; Rossella Donghia; Vito Guerra; Roberta Zupo; Giovanni De Pergola; Marta Di Masi; Gianluigi Giannelli; Madia Lozupone; Francesco Panza; Heiner Boeing; Rodolfo Sardone Journal: Int J Environ Res Public Health Date: 2021-12-09 Impact factor: 3.390